Surmodics | SRDX - Current Liabilities


Surmodics reported $20.54M in Current Liabilities for its fiscal quarter ending in September of 2024.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Align Technology USD 1.92B 46.45M Dec/2025
Anika Therapeutics USD 21.91M 2.82M Dec/2025
Arrowhead Research USD 347.42M 151.94M Dec/2025
Artivion USD 101.56M 15.72M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
EDAP TMS EUR 31.4M 2.71M Sep/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Haemonetics USD 539.87M 8.45M Dec/2025
Heron Therapeutics USD 96.1M 6.39M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Merit Medical Systems USD 239.76M 9.29M Dec/2025
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Nektar Therapeutics USD 66.34M 5.05M Sep/2025
Option Care Health USD 829.35M 5.44M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Surmodics USD 20.54M 347K Sep/2024
Trinity Biotech USD 34.49M 2.97M Sep/2025